A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Revelation Biosciences Inc Wt stock. As of the latest transaction made, Citadel Advisors LLC holds 29,400 shares of REVBW stock, worth $294. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,400
Previous 45,853 35.88%
Holding current value
$294
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.01 - $0.03 $164 - $493
-16,453 Reduced 35.88%
29,400 $0
Q2 2024

Aug 14, 2024

SELL
$0.01 - $0.03 $6 - $20
-674 Reduced 1.45%
45,853 $0
Q1 2024

May 15, 2024

BUY
$0.01 - $0.03 $322 - $967
32,266 Added 226.25%
46,527 $1,000
Q4 2023

Feb 14, 2024

SELL
$0.01 - $0.02 $22 - $44
-2,220 Reduced 13.47%
14,261 $0
Q3 2023

Nov 14, 2023

BUY
$0.01 - $0.02 $17 - $35
1,761 Added 11.96%
16,481 $0
Q2 2023

Aug 14, 2023

SELL
$0.01 - $0.02 $24 - $48
-2,419 Reduced 14.11%
14,720 $0
Q1 2023

May 15, 2023

BUY
$0.02 - $0.04 $342 - $685
17,139 New
17,139 $0

Others Institutions Holding REVBW

About REVELATION BIOSCIENCES INC WT


  • Ticker REVBW
More about REVBW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.